Logo image of KRMN

KARMAN HOLDINGS INC (KRMN) Stock Fundamental Analysis

NYSE:KRMN - US4859241048 - Common Stock

54.69 USD
+1.65 (+3.11%)
Last: 8/26/2025, 8:04:00 PM
55.25 USD
+0.56 (+1.02%)
After Hours: 8/26/2025, 8:04:00 PM
Fundamental Rating

4

Overall KRMN gets a fundamental rating of 4 out of 10. We evaluated KRMN against 68 industry peers in the Aerospace & Defense industry. KRMN has an average financial health and profitability rating. KRMN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year KRMN was profitable.
KRMN Yearly Net Income VS EBIT VS OCF VS FCFKRMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With a Return On Assets value of 1.54%, KRMN perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
KRMN has a Return On Equity (4.07%) which is in line with its industry peers.
KRMN has a Return On Invested Capital of 9.59%. This is amongst the best in the industry. KRMN outperforms 83.82% of its industry peers.
KRMN had an Average Return On Invested Capital over the past 3 years of 6.11%. This is below the industry average of 8.40%.
The 3 year average ROIC (6.11%) for KRMN is below the current ROIC(9.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.54%
ROE 4.07%
ROIC 9.59%
ROA(3y)0.06%
ROA(5y)N/A
ROE(3y)0.31%
ROE(5y)N/A
ROIC(3y)6.11%
ROIC(5y)N/A
KRMN Yearly ROA, ROE, ROICKRMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 5 -5

1.3 Margins

The Profit Margin of KRMN (2.62%) is comparable to the rest of the industry.
KRMN's Operating Margin of 16.70% is amongst the best of the industry. KRMN outperforms 88.24% of its industry peers.
The Gross Margin of KRMN (39.00%) is better than 79.41% of its industry peers.
Industry RankSector Rank
OM 16.7%
PM (TTM) 2.62%
GM 39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRMN Yearly Profit, Operating, Gross MarginsKRMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

KRMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, KRMN has about the same amount of shares outstanding.
KRMN has a worse debt/assets ratio than last year.
KRMN Yearly Shares OutstandingKRMN Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
KRMN Yearly Total Debt VS Total AssetsKRMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 8.42 indicates that KRMN is not in any danger for bankruptcy at the moment.
KRMN has a Altman-Z score of 8.42. This is amongst the best in the industry. KRMN outperforms 80.88% of its industry peers.
A Debt/Equity ratio of 1.30 is on the high side and indicates that KRMN has dependencies on debt financing.
KRMN has a Debt to Equity ratio of 1.30. This is in the lower half of the industry: KRMN underperforms 79.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Altman-Z 8.42
ROIC/WACC0.93
WACC10.29%
KRMN Yearly LT Debt VS Equity VS FCFKRMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

KRMN has a Current Ratio of 2.75. This indicates that KRMN is financially healthy and has no problem in meeting its short term obligations.
KRMN's Current ratio of 2.75 is fine compared to the rest of the industry. KRMN outperforms 60.29% of its industry peers.
A Quick Ratio of 2.58 indicates that KRMN has no problem at all paying its short term obligations.
KRMN has a better Quick ratio (2.58) than 77.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.58
KRMN Yearly Current Assets VS Current LiabilitesKRMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 191.21% over the past year.
KRMN shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.99%.
EPS 1Y (TTM)191.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)22.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

KRMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 95.03% yearly.
The Revenue is expected to grow by 22.83% on average over the next years. This is a very strong growth
EPS Next Y307.69%
EPS Next 2Y143.2%
EPS Next 3Y95.03%
EPS Next 5YN/A
Revenue Next Year31.3%
Revenue Next 2Y24.31%
Revenue Next 3Y22.83%
Revenue Next 5YN/A

3.3 Evolution

KRMN Yearly Revenue VS EstimatesKRMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
KRMN Yearly EPS VS EstimatesKRMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 497.18, which means the current valuation is very expensive for KRMN.
Based on the Price/Earnings ratio, KRMN is valued a bit more expensive than 61.76% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.08, KRMN is valued quite expensively.
The Price/Forward Earnings ratio is 92.98, which means the current valuation is very expensive for KRMN.
KRMN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. KRMN is more expensive than 61.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.67. KRMN is valued rather expensively when compared to this.
Industry RankSector Rank
PE 497.18
Fwd PE 92.98
KRMN Price Earnings VS Forward Price EarningsKRMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as KRMN.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 60.81
KRMN Per share dataKRMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

KRMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as KRMN's earnings are expected to grow with 95.03% in the coming years.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y143.2%
EPS Next 3Y95.03%

0

5. Dividend

5.1 Amount

No dividends for KRMN!.
Industry RankSector Rank
Dividend Yield N/A

KARMAN HOLDINGS INC

NYSE:KRMN (8/26/2025, 8:04:00 PM)

After market: 55.25 +0.56 (+1.02%)

54.69

+1.65 (+3.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)N/A N/A
Inst Owners25.91%
Inst Owner Change3.43%
Ins Owners4.25%
Ins Owner Change-2.92%
Market Cap7.24B
Analysts87.27
Price Target59.5 (8.8%)
Short Float %6.61%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.73%
Min EPS beat(2)0.55%
Max EPS beat(2)100.9%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4%
Min Revenue beat(2)3.13%
Max Revenue beat(2)4.87%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.44%
PT rev (3m)50.54%
EPS NQ rev (1m)-2.57%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.63%
EPS NY rev (3m)0.18%
Revenue NQ rev (1m)6.91%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.8%
Revenue NY rev (3m)6.17%
Valuation
Industry RankSector Rank
PE 497.18
Fwd PE 92.98
P/S 12.91
P/FCF N/A
P/OCF N/A
P/B 20.02
P/tB N/A
EV/EBITDA 60.81
EPS(TTM)0.11
EY0.2%
EPS(NY)0.59
Fwd EY1.08%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.24
BVpS2.73
TBVpS-1.45
PEG (NY)1.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 4.07%
ROCE 10.81%
ROIC 9.59%
ROICexc 9.9%
ROICexgc 29.08%
OM 16.7%
PM (TTM) 2.62%
GM 39%
FCFM N/A
ROA(3y)0.06%
ROA(5y)N/A
ROE(3y)0.31%
ROE(5y)N/A
ROIC(3y)6.11%
ROIC(5y)N/A
ROICexc(3y)6.19%
ROICexc(5y)N/A
ROICexgc(3y)19.58%
ROICexgc(5y)N/A
ROCE(3y)6.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Debt/EBITDA 3.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 2.58
Altman-Z 8.42
F-ScoreN/A
WACC10.29%
ROIC/WACC0.93
Cap/Depr(3y)56.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.6%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)191.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y307.69%
EPS Next 2Y143.2%
EPS Next 3Y95.03%
EPS Next 5YN/A
Revenue 1Y (TTM)22.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year31.3%
Revenue Next 2Y24.31%
Revenue Next 3Y22.83%
Revenue Next 5YN/A
EBIT growth 1Y31.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.52%
EBIT Next 3Y44.81%
EBIT Next 5YN/A
FCF growth 1Y220.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.09%
OCF growth 3YN/A
OCF growth 5YN/A